Key facts
- Manuals
- 1
- Languages
- ZH
- Last added
- 2026-10-01
Featured Fresenius Kabi manuals

Fresenius Kabi Compound α‑Ketoacid Tablets Product Leaflet
This leaflet provides comprehensive information on Fresenius Kabi’s Compound α‑Ketoacid Tablets, a multi‑component oral formulation used in conjunction with a low‑protein diet to manage metabolic disturbances in chronic kidney disease. It lists the active keto‑amino‑acid calcium salts, essential amino acids, and total nitrogen and calcium content per tablet.
The document outlines indications, recommended dosage (4‑8 tablets three times daily for a 70 kg adult), contraindications, precautions, drug interactions, pharmacology, and storage conditions. It also includes regulatory details such as approval number, manufacturing company, and packaging specifications. This manual is written in Chinese.
Covers: Composition · Indications · Dosage and Administration · Contraindications · Adverse Reactions · Drug Interactions
Latest Fresenius Kabi manuals
Fresenius Kabi Compound α‑Ketoacid Tablets Product Leaflet
Product Leaflet 4 pages · 163 KB · ZHProduct leaflet for Fresenius Kabi Compound α‑Ketoacid Tablets, detailing composition, dosage, indications, and safety information.
Questions answered in Fresenius Kabi manuals
What are the contraindications for this medication?
The product should not be used in patients with hypercalcemia, amino‑acid metabolism disorders, or phenylketonuria because it contains phenylalanine.
From: Fresenius Kabi Compound α‑Ketoacid Tablets Product Leaflet
What safety monitoring is required while taking the tablets?
Blood calcium levels should be regularly monitored, and care should be taken to avoid excessive calcium intake from other sources.
From: Fresenius Kabi Compound α‑Ketoacid Tablets Product Leaflet
